Jfs Wealth Advisors, LLC Amgen Inc Transaction History

Jfs Wealth Advisors, LLC

$1.49 Billion
Q3 2024

A detailed history of Jfs Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 935 shares of AMGN stock, worth $275,385. This represents 0.02% of its overall portfolio holdings.

Number of Shares

935

Previous 956 2.2%

Holding current value

$275,385

Previous $298,000 1.01%

% of portfolio

0.02%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $6,496 - $7,084	-21 Reduced 2.2%	935 $301,000
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $12,086 - $14,688	-46 Reduced 4.59%	956 $298,000
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $1,344 - $1,622	5 Added 0.5%	1,002 $284,000
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $6,136 - $6,923	24 Added 2.47%	997 $287,000
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $41,762 - $51,848	191 Added 24.42%	973 $261,000
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $60,209 - $71,196	-281 Reduced 26.43%	782 $173,000
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $13,321 - $16,236	-59 Reduced 5.26%	1,063 $256,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $20,154 - $25,608	-88 Reduced 7.27%	1,122 $294,000
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $4,264 - $4,809	-19 Reduced 1.55%	1,210 $273,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $21,225 - $23,620	92 Added 8.09%	1,229 $299,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $35,741 - $39,538	163 Added 16.74%	1,137 $275,000
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $11,932 - $13,656	60 Added 6.56%	974 $219,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $80,109 - $93,354	-361 Reduced 28.31%	914 $227,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $107,757 - $128,319	498 Added 64.09%	1,275 $293,000
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $23,465 - $26,095	-100 Reduced 11.4%	777 $197,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $9,099 - $11,166	46 Added 5.54%	877 $207,000
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $696 - $834	4 Added 0.48%	831 $161,000
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $19,172 - $21,611	-106 Reduced 11.36%	827 $157,000
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $130,588 - $152,439	-732 Reduced 43.96%	933 $182,000
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $15,008 - $16,920	81 Added 5.11%	1,665 $345,000
Q2 2018 Jul 26, 2018	BUY	$166.05 - $186.51 $664 - $746	4 Added 0.25%	1,584 $292,000
Q1 2018 Apr 26, 2018	SELL	$169.43 - $198.0 $6,438 - $7,524	-38 Reduced 2.35%	1,580 $269,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $270,675 - $309,038	1,618	1,618 $302,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.

Account

Jfs Wealth Advisors, LLC Amgen Inc Transaction History